Clue vs Ovia 2026: Privacy, Features & Price Compared

Clue and Ovia occupy different niches in the women's health app market. Clue is a science-forward cycle tracker built by BioWink GmbH in Berlin, with research partnerships and CE Class 1 medical device certification. Ovia is a fertility-to-parenting platform owned by Labcorp, focused on the trying-to-conceive (TTC) through postpartum journey.

Clue appeals to users who want data-driven cycle understanding with minimal marketing noise. Ovia appeals to users planning or experiencing pregnancy, with daily fertility scores, health coaching, and milestone tracking across three separate apps (Fertility, Pregnancy, Parenting).

The fundamental difference isn't features — it's business model. Clue charges subscriptions and doesn't sell user data. Ovia is "free" because Labcorp sells enterprise access to employee health analytics. One makes money from you; the other makes money from your data.

Clue has one of the stronger privacy postures in the period tracking industry. Based in Berlin, operating under GDPR, storing data on EU servers, and publicly committed to never selling user data. No major breaches or enforcement actions. For a cloud-based app, Clue is as good as it gets.

Ovia is the opposite. As a Labcorp subsidiary, its business model depends on monetizing health data through corporate partnerships. Ovia+ sells employers and health plans access to employee reproductive health analytics. Mozilla flagged Ovia with "Privacy Not Included." Snopes confirmed mandatory location data collection.

The contrast is stark: Clue earns revenue from subscriptions while protecting your data. Ovia earns revenue by making your data available to corporate partners. For users choosing between the two, privacy alone should settle the debate.

But even Clue's strong posture can't match architecture that eliminates cloud storage. PinkyBloom's zero-knowledge design means no servers, no accounts, and no data to access — not by companies, not by employers, not by anyone.

Clue's strength is cycle analytics: research-backed predictions, custom tags, the Analysis tab, and clean data visualization. Clue Plus unlocks advanced predictions and Conceive mode. The interface is minimal and focused on data.

Ovia's strength is the pregnancy journey: daily fertility scores, pregnancy milestone tracking, health coaching, and a large content library. The three-app approach (Fertility, Pregnancy, Parenting) provides specialized experiences but fragments your health data across separate applications.

Neither offers AI-powered features. No conversational assistant, no voice logging, no predictive mood forecasting. Both rely on manual input and pre-written content rather than personalized AI analysis.

PinkyBloom covers both apps' strengths in a single app. On-device AI provides cycle analytics and pregnancy support. Voice logging replaces manual input. AI mood forecasts predict emotional patterns. The doctor visit report generator is invaluable for prenatal appointments. All life stages in one app, zero servers, zero cost.

Clue Plus costs $39.99/year — a straightforward subscription for a quality product. Ovia is free for consumers, but subsidized by employers paying Labcorp for health analytics.

The real price comparison isn't about dollars. Clue costs money but respects your data. Ovia costs nothing but monetizes your reproductive health through corporate partnerships. When a Labcorp-owned app is free, the product isn't the app — it's you.

PinkyBloom is free with no hidden cost. No subscription, no employer subsidy, no corporate data partnerships. Every feature included. The total cost in every dimension — financial, privacy, and data — is zero.